Added to YB: 2026-03-19
Pitch date: 2026-03-17
AEMD [neutral]
Aethlon Medical, Inc.
Author Info
No bio for this author
Company Info
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States.
Market Cap
$2.8M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.58
P/E
-0.07
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
special_situation
KEDM Lite Vol. 6 - Aethlon Medical, Inc.
AEMD (update): Exploring strategic options after receiving inbound interest while advancing oncology clinical trial in Australia (2nd cohort complete, safety data under review). Market skeptical of research but trades at negative EV with large net cash position & potential valuable IP worth investigating.
Read full article (1 min)